Prab: CSV import

2025-03-17T19:24:18Z

CSV import

← Older revision		Revision as of 19:24, 17 March 2025
Line 31:		Line 31:
	{{medicine-stub}}		{{medicine-stub}}
	{{No image}}		{{No image}}
			__NOINDEX__

Prab: CSV import

2025-02-11T04:14:40Z

CSV import

← Older revision		Revision as of 04:14, 11 February 2025
Line 30:		Line 30:
	[[Category:Pharmacology]]		[[Category:Pharmacology]]
	{{medicine-stub}}		{{medicine-stub}}
			{{No image}}

Prab: CSV import

2024-02-29T06:38:58Z

CSV import

New page

'''Multicenter trial''' is a type of [[clinical trial]] that is conducted at more than one [[medical center]] or [[clinic]]. These trials are often used in the field of [[medicine]] and [[pharmacology]] to test the safety and efficacy of new [[drugs]] or [[medical devices]].

== Overview ==

Multicenter trials are designed to provide more data than a single-center trial. They involve multiple, geographically dispersed locations that all follow the same [[protocol]] for the trial. This allows for a larger number of participants, increased generalizability, and the ability to compare results across different populations and settings.

== Design and Implementation ==

The design and implementation of a multicenter trial involves several key steps. First, a detailed [[study protocol]] is developed, outlining the objectives, design, methodology, statistical considerations, and organization of the trial. This protocol is then reviewed and approved by an [[ethics committee]] or [[institutional review board]] at each participating center.

Once the protocol is approved, [[patient recruitment]] begins. Participants are typically randomized into different groups, such as a treatment group that receives the experimental drug or device, and a control group that receives a placebo or standard treatment.

Data from the trial is collected and analyzed by a [[data coordinating center]]. This center is responsible for ensuring data quality and integrity, and for analyzing the results of the trial.

== Advantages and Disadvantages ==

Multicenter trials have several advantages over single-center trials. They allow for a larger number of participants, which can increase the statistical power of the study. They also allow for greater diversity in the participant population, which can increase the generalizability of the results.

However, multicenter trials also have potential disadvantages. They can be more complex and costly to manage than single-center trials. There can also be variability in the implementation of the protocol across different centers, which can introduce bias into the study.

== See Also ==

* [[Clinical trial]]
* [[Randomized controlled trial]]
* [[Cohort study]]
* [[Observational study]]

[[Category:Clinical research]]
[[Category:Medical terminology]]
[[Category:Pharmacology]]
{{medicine-stub}}

Multicenter trial - Revision history

Prab: CSV import

Prab: CSV import

Prab: CSV import